假体间股骨骨折手术治疗的结果
回顾性分析76例假体间股骨骨折患者,平均随访7年。57例(75%)行ORIF,18例(24%)行翻修置换。ORIF与翻修组两年无再手术生存率分别为82%和77%,总体81%。末次随访95%患者可行走。
要点
- 假体间股骨骨折以ORIF为主要治疗方式,翻修置换占24%
- ORIF后骨不连与非骨水泥柄膝假体及假体间距较大相关
- 翻修后骨不连与髓腔直径/皮质宽度比高及假体间距小相关
核心结论
- 假体间股骨骨折是技术和生物学上具有挑战性的病例,个体化选择内固定或翻修置换可获得81%的两年无再手术生存率,95%患者末次随访可行走。
研究设计与样本
- 回顾性队列研究,纳入1985年2月至2018年4月治疗的76例假体间股骨骨折患者,平均年龄74岁,平均BMI 30 kg/m2,平均随访7年。
主要发现
- 59例为Vancouver C(UCS D)型,17例为Vancouver B(UCS B)型。
- 57例(75%)行ORIF,其中3例骨不连、3例假体周围感染、2例无菌性松动。
- 18例(24%)行翻修置换(13例翻修THA、4例远端股骨置换、1例翻修TKA),其中1例无菌性松动、2例骨不连。
- ORIF组和翻修组两年无再手术生存率分别为82%(95%CI 66.9%-90.6%)和77%(95%CI 49.4%-90.7%)。
- ORIF后骨不连患者假体间距均值189 mm(SD 73.6) vs 163 mm(SD 36.7),p=0.546;翻修后骨不连患者髓腔直径/皮质宽度比2.5(SD 1.7) vs 1.3(SD 0.3),p=0.008,假体间距36 mm(SD 30.6) vs 214 mm(SD 32.1),p<0.001。
临床怎么用
- 对于假体间股骨骨折,可根据骨折类型和患者因素个体化选择ORIF或翻修置换。
- ORIF时需注意膝假体柄类型和假体间距对骨愈合的影响。
- 翻修置换时需评估髓腔直径/皮质宽度比和假体间距对骨不连风险的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The prevalence of ipsilateral total hip arthroplasty (THA) and total knee arthroplasty (TKA) is rising in concert with life expectancy, putting more patients at risk for interprosthetic femur fractures (IPFFs). Our study aimed to assess treatment methodologies, implant survivorship, and IPFF clinical outcomes. METHODS: A total of 76 patients treated for an IPFF from February 1985 to April 2018 were reviewed. Prior to fracture, at the hip/knee sites respectively, 46 femora had primary/primary, 21 had revision/primary, three had primary/revision, and six had revision/revision components. Mean age and BMI were 74 years (33 to 99) and 30 kg/m2 (21 to 46), respectively. Mean follow-up after fracture treatment was seven years (2 to 24). RESULTS: Overall, 59 fractures were classified as Vancouver C (Unified Classification System (UCS) D), 17 were Vancouver B (UCS B). In total, 57 patients (75%) were treated with open reduction and internal fixation (ORIF); three developed nonunion, three developed periprosthetic joint infection, and two developed aseptic loosening. In all, 18 patients (24%) underwent revision arthroplasty including 13 revision THAs, four distal femoral arthroplasties (DFAs), and one revision TKA: of these, one patient developed aseptic loosening and two developed nonunion. Survivorship free from any reoperation was 82% (95% confidence interval (CI) 66.9% to 90.6%) and 77% (95% CI 49.4% to 90.7%) in the ORIF and revision groups at two years, respectively. ORIF patients who went on to union tended to have stemmed knee components and greater mean interprosthetic distance (IPD = 189 mm (SD 73.6) vs 163 mm (SD 36.7); p = 0.546) than nonunited fractures. Patients who went on to nonunion in the revision arthroplasty group had higher medullary diameter: cortical width ratio (2.5 (SD 1.7) vs 1.3 (SD 0.3); p = 0.008) and lower IPD (36 mm (SD 30.6) vs 214 mm (SD 32.1); p < 0.001). At latest follow-up, 95% of patients (n = 72) were ambulatory. CONCLUSION: Interprosthetic femur fractures are technically and biologically challenging cases. Individualized approaches to internal fixation versus revision arthroplasty led to an 81% (95% CI 68.3% to 88.6%) survivorship free from reoperation at two years with 95% of patients ambulatory. Continued improvements in management are warranted. Cite this article: Bone Joint J 2021;103-B(7 Supple B):122-128.
引用
- Tibbo ME, Limberg AK, Gausden EB, et al. Outcomes of operatively treated interprosthetic femoral fractures. Bone Joint J. 2021. PMID: 34192901. doi:10.1302/0301-620X.103B7.BJJ-2020-2275.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。